[go: up one dir, main page]

BR9911679A - Paroxetine salts - Google Patents

Paroxetine salts

Info

Publication number
BR9911679A
BR9911679A BR9911679-0A BR9911679A BR9911679A BR 9911679 A BR9911679 A BR 9911679A BR 9911679 A BR9911679 A BR 9911679A BR 9911679 A BR9911679 A BR 9911679A
Authority
BR
Brazil
Prior art keywords
paroxetine salts
paroxetine
salts
therapy
preparing
Prior art date
Application number
BR9911679-0A
Other languages
Portuguese (pt)
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9911679A publication Critical patent/BR9911679A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SAIS DE PAROXETINA". São revelados compostos de piperidina, processos para preparação dos mesmos, composições farmacêuticas contendo os mesmos e sua utilização na terapia."PAROXETINE SALTS". Piperidine compounds, processes for preparing them, pharmaceutical compositions containing them and their use in therapy are disclosed.

BR9911679-0A 1998-07-02 1999-06-30 Paroxetine salts BR9911679A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (1)

Publication Number Publication Date
BR9911679A true BR9911679A (en) 2002-01-29

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911679-0A BR9911679A (en) 1998-07-02 1999-06-30 Paroxetine salts

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266584B1 (en) 2003-05-07 2012-09-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
WO2004098619A2 (en) 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
WO2005108339A2 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) 2004-09-21 2007-01-19 주식회사종근당 Choline or Choline Derivative Salts of Paroxetine
JP2010504281A (en) * 2006-07-27 2010-02-12 エミスフェアー・テクノロジーズ・インク Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof
CN116283778B (en) * 2023-02-23 2025-08-29 江苏理工学院 A pyrazole carboxylic acid compound and its preparation method and application
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
KR100543614B1 (en) * 1997-06-10 2006-01-20 신톤 비.브이. 4-phenylpiperidine compound
SK11812000A3 (en) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Salts of paroxetine

Also Published As

Publication number Publication date
GB9814316D0 (en) 1998-09-02
HUP0103712A3 (en) 2002-09-30
AU2002100370A4 (en) 2002-06-06
BG105204A (en) 2001-11-30
WO2000001692A1 (en) 2000-01-13
NO20006547D0 (en) 2000-12-21
TR200100055T2 (en) 2001-07-23
ZA200100020B (en) 2002-03-25
HUP0103712A2 (en) 2002-05-29
JP2002519421A (en) 2002-07-02
NO20006547L (en) 2001-02-12
EP1091958A1 (en) 2001-04-18
ID27766A (en) 2001-04-26
SK20242000A3 (en) 2001-07-10
ZA992899B (en) 2000-03-29
CA2336470A1 (en) 2000-01-13
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (en) 2001-08-15
KR20010053337A (en) 2001-06-25
AU4903999A (en) 2000-01-24
CN1314906A (en) 2001-09-26
PL345365A1 (en) 2001-12-17
EA200100098A1 (en) 2001-08-27
IL140385A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
DK199900554A (en) Paroxetine salts, process for their preparation, pharmaceutical compositions comprising these and uses thereof
EE04399B1 (en) Spiroazabicyclic Heterocyclic Compounds, Process for their Preparation, Pharmaceutical Compositions Containing Them and Their Use in Therapy
NO20002787L (en) New connections
EE200000320A (en) Novel compounds
SE9704544D0 (en) Novel compounds
FI955024A7 (en) Novel piperidine compounds, process for their preparation and pharmaceutical compositions containing them
FI973039A7 (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them
FI973279A7 (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them
EE9800028A (en) Iprotropium salts, pharmaceutical compositions containing them and their use
NO973922D0 (en) New taxoids, their preparation and pharmaceutical compositions containing the compounds
ATE345133T1 (en) LACTOSE-FREE, NON-HYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL COMPOSITIONS OF DESCARBOETHOXYLORATADINE
PT839041E (en) The invention relates to a process for preparing a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of medicaments.
BR9911679A (en) Paroxetine salts
IS5851A (en) New Oral 5-HT4 Agents or Antagonists
EE200000657A (en) Azoles, process for their preparation, use as a pharmaceutical and pharmaceutical composition
PT862575E (en) The invention relates to a process for preparing a pharmaceutical composition comprising
BR0318659A (en) proline derivatives used as active pharmaceutical ingredients in the treatment of tumors
PT1017681E (en) PHARMACEUTICAL AND INTERMEDIATE COMPOUNDS
BR9802803A (en) action and pharmaceutical compositions containing them.
NO20013878D0 (en) (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, process for their preparation and pharmaceutical compositions containing the same
ATE397447T1 (en) SOLID PREPARATIONS CONTAINING PAROXETINE
FI950818L (en) Novel substituted sulfonamides, process for their preparation and pharmaceutical compositions containing them
SE9803277D0 (en) Novel compounds
FI951296A7 (en) Novel aminoalkylbenzothiazolinones, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]